Team:XJTU-China/Human Practices

In order to improve our projects, we have several interviews with experts in Microbiology, Medicine and Food, to collect information about diabetes, sweeteners, advantage of D-psicose as well as market and possible commercialization of D-psicose. Additionally,we visited the elders and patients in Xi'an Jinqiu Nursing Home, Xi’an Jiaotong University community and hospital, to collect their problems on medical treatment and daily diet, as well as to popularize our projects about healthy sugar substitutes D-psicose. In our WeChat public account, we not only introduce and promote the IGEM competition concept and our project, we also regularly post scientific articles in synthetic biology to gradually walk the public into life sciences.

Our human practice work is integrated into different stages of the project. To learn about the possibility of D-psicose as a drug for the treatment of diabetes,We had a deep interview with Dr Guo, who is a doctor for diabetes treatment. To collect some information about the current sweetener market, and situation of sugar production, we visit companies related to sugar production. To investigate the public's perception about sweeteners and predict the future market of our products, D-psicose,we have collected over one thousand questionaires.

Public participation is very important given that the IGEM competition is a competition that was born to solve practical problems. We actively joined various communities to involve the public into our project. Social media like Wechat public account, Twitter, and public mailbox are constantly used to communicate with the public and other teams. We also conducted questionnaires for online and offline surveys. In addition, social practice of IGEM competition is including offering lectures on synthetic biology, visiting nursing homes, and handing out health manuals.





In order to improve our projects, we have several interviews with experts in Microbiology, Medicine and Food, to collect information about diabetes, sweeteners, advantage of D-psicose as well as market and possible commercialization of D-psicose.

Part 1: Diabetes and possible positive effects of D-psicose on diabetes

Director of endocrinology department in First Affiliated Hospital of Xi'an Jiaotong University

We had a deep interview with Dr Guo, who is a doctor for diabetes treatment, to learn about the possibility of D-psicose as a drug for the treatment of diabetes.

Keypoints

  • D-psicose is suitable for the treatment of obesity and almost all types of diabetes (multi-site functions), which is very advantageous as a potential drug.
  • Safety of D-psicose is the major concern, and a series of clinical trials is needed before commercialization.
  • Diet control is very important to control blood sugar level and its intakes. A reasonable diet pyramid should be paid attention to for the diabetics.

Professor major in food and medicine, Xi’an Jiaotong University
an associate professor in Shaanxi Institute of Bio-Agriculture

Prof. Zhang, who focuses her research on the food and medical mechanism of D-psicose, as well as Dr. Gan-Qiao Ran, who works on medical effects and production of D-psicose, introduced us some reported results about detailed effects of D-psicose.

Keypoints

  • In rodents, D-psicose is known to inhibit digestive enzymes, including alpha-glucosidase and alpha-amylase. D-psicose also inhibits the absorption of glucose from the intestine by competing with glucose transporter 2 (GLUT2) on the basolateral membrane of intestinal epithelial cells.
  • In rats, D-psicose-induced hepatic glucokinase has been reported to improve hepatic glucose utilization.
  • Rats fed D-psicose had significantly lower serum insulin and leptin levels. The D-psicose diet significantly reduced liver enzyme activity involved in adipogenesis, while gene expression of fatty acid oxidative transcriptional regulators was enhanced.